Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer

Detalles Bibliográficos
Autores principales: Proskurina, Anastasia S., Gvozdeva, Tatiana S., Alyamkina, Ekaterina A., Dolgova, Evgenia V., Orishchenko, Konstantin E., Nikolin, Valeriy P., Popova, Nelly A., Sidorov, Sergey V., Chernykh, Elena R., Ostanin, Alexandr A., Leplina, Olga Y., Dvornichenko, Victoria V., Ponomarenko, Dmitriy M., Soldatova, Galina S., Varaksin, Nikolay A., Ryabicheva, Tatiana G., Uchakin, Peter N., Zagrebelniy, Stanislav N., Rogachev, Vladimir A., Bogachev, Sergey S., Shurdov, Mikhail A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757989/
https://www.ncbi.nlm.nih.gov/pubmed/26887451
http://dx.doi.org/10.1186/s12885-016-2163-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757989/
https://www.ncbi.nlm.nih.gov/pubmed/26887451
http://dx.doi.org/10.1186/s12885-016-2163-y

Ejemplares similares